Makoto Kawai1,2, Ruth O'Hara1,2, Mali Einen3, Ling Lin3, Emmanuel Mignot3. 1. Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Stanford, CA. 2. Sierra Pacific Mental Illness Research Education and Clinical Centers, VA Palo Alto Health Care System, Palo Alto, CA. 3. Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University, School of Medicine, Palo Alto, CA.
Abstract
STUDY OBJECTIVES: Although narcolepsy affects 0.02-0.05% of individuals in various ethnic groups, clinical presentation in different ethnicities has never been fully characterized. Our goal was to study phenotypic expression across ethnicities in the United States. DESIGN/ SETTING: Cases of narcolepsy from 1992 to 2013 were identified from searches of the Stanford Center for Narcolepsy Research database. International Classification of Sleep Disorders, Third Edition diagnosis criteria for type 1 and type 2 narcolepsy were used for inclusion, but subjects were separated as with and without cataplexy for the purpose of data presentation. Information extracted included demographics, ethnicity and clinical data, HLA-DQB1*06:02, polysomnography (PSG), multiple sleep latency test (MSLT) data, and cerebrospinal fluid (CSF) hypocretin-1 level. PATIENTS: 182 African-Americans, 839 Caucasians, 35 Asians, and 41 Latinos with narcolepsy. RESULTS: Sex ratio, PSG, and MSLT findings did not differ across ethnicities. Epworth Sleepiness Scale (ESS) score was higher and age of onset of sleepiness earlier in African Americans compared with other ethnicities. HLA-DQB1*06:02 positivity was higher in African Americans (91.0%) versus others (76.6% in Caucasians, 80.0% in Asians, and 65.0% in Latinos). CSF hypocretin-1 level, obtained in 222 patients, was more frequently low (≤ 110 pg/ml) in African Americans (93.9%) versus Caucasians (61.5%), Asians (85.7%) and Latinos (75.0%). In subjects with low CSF hypocretin-1, African Americans (28.3%) were 4.5 fold more likely to be without cataplexy when compared with Caucasians (8.1%). CONCLUSIONS: Narcolepsy in African Americans is characterized by earlier symptom onset, higher Epworth Sleepiness Scale score, higher HLA-DQB1*06:02 positivity, and low cerebrospinal fluid hypocretin-1 level in the absence of cataplexy. In African Americans, more subjects without cataplexy have type 1 narcolepsy.
STUDY OBJECTIVES: Although narcolepsy affects 0.02-0.05% of individuals in various ethnic groups, clinical presentation in different ethnicities has never been fully characterized. Our goal was to study phenotypic expression across ethnicities in the United States. DESIGN/ SETTING: Cases of narcolepsy from 1992 to 2013 were identified from searches of the Stanford Center for Narcolepsy Research database. International Classification of Sleep Disorders, Third Edition diagnosis criteria for type 1 and type 2 narcolepsy were used for inclusion, but subjects were separated as with and without cataplexy for the purpose of data presentation. Information extracted included demographics, ethnicity and clinical data, HLA-DQB1*06:02, polysomnography (PSG), multiple sleep latency test (MSLT) data, and cerebrospinal fluid (CSF) hypocretin-1 level. PATIENTS: 182 African-Americans, 839 Caucasians, 35 Asians, and 41 Latinos with narcolepsy. RESULTS: Sex ratio, PSG, and MSLT findings did not differ across ethnicities. Epworth Sleepiness Scale (ESS) score was higher and age of onset of sleepiness earlier in African Americans compared with other ethnicities. HLA-DQB1*06:02 positivity was higher in African Americans (91.0%) versus others (76.6% in Caucasians, 80.0% in Asians, and 65.0% in Latinos). CSF hypocretin-1 level, obtained in 222 patients, was more frequently low (≤ 110 pg/ml) in African Americans (93.9%) versus Caucasians (61.5%), Asians (85.7%) and Latinos (75.0%). In subjects with low CSF hypocretin-1, African Americans (28.3%) were 4.5 fold more likely to be without cataplexy when compared with Caucasians (8.1%). CONCLUSIONS:Narcolepsy in African Americans is characterized by earlier symptom onset, higher Epworth Sleepiness Scale score, higher HLA-DQB1*06:02 positivity, and low cerebrospinal fluid hypocretin-1 level in the absence of cataplexy. In African Americans, more subjects without cataplexy have type 1 narcolepsy.
Authors: Yves Dauvilliers; Jacques Montplaisir; Valéerie Cochen; Alex Desautels; Mali Einen; Ling Lin; Minae Kawashima; Sophie Bayard; Christelle Monaca; Michel Tiberge; Daniel Filipini; Asit Tripathy; Bich Hong Nguyen; Suresh Kotagal; Emmanuel Mignot Journal: Sleep Date: 2010-11 Impact factor: 5.849
Authors: Y K Shin; I Y Yoon; E K Han; Y M No; M C Hong; Y D Yun; B K Jung; S H Chung; J B Choi; J G Cyn; Y J Lee; S C Hong Journal: Acta Neurol Scand Date: 2007-10-08 Impact factor: 3.209
Authors: W T Longstreth; Thanh G N Ton; Thomas Koepsell; Vivian H Gersuk; Audrey Hendrickson; Sarah Velde Journal: Sleep Med Date: 2008-11-13 Impact factor: 3.492
Authors: Joachim Hallmayer; Juliette Faraco; Ling Lin; Stephanie Hesselson; Juliane Winkelmann; Minae Kawashima; Geert Mayer; Giuseppe Plazzi; Sona Nevsimalova; Patrice Bourgin; Seung-Chul Hong; Sheng Seung-Chul Hong; Yutaka Honda; Makoto Honda; Birgit Högl; William T Longstreth; Jacques Montplaisir; David Kemlink; Mali Einen; Justin Chen; Stacy L Musone; Matthew Akana; Taku Miyagawa; Jubao Duan; Alex Desautels; Christine Erhardt; Per Egil Hesla; Francesca Poli; Birgit Frauscher; Jong-Hyun Jeong; Sung-Pil Lee; Thanh G N Ton; Mark Kvale; Libor Kolesar; Marie Dobrovolná; Gerald T Nepom; Dan Salomon; H-Erich Wichmann; Guy A Rouleau; Christian Gieger; Douglas F Levinson; Pablo V Gejman; Thomas Meitinger; Terry Young; Paul Peppard; Katsushi Tokunaga; Pui-Yan Kwok; Neil Risch; Emmanuel Mignot Journal: Nat Genet Date: 2009-05-03 Impact factor: 38.330
Authors: Noeen Sarfraz; David Okuampa; Hannah Hansen; Mark Alvarez; Elyse M Cornett; Juyeon Kakazu; Adam M Kaye; Alan D Kaye Journal: Health Psychol Res Date: 2022-05-30
Authors: Adrienne Elisabeth van der Hoeven; Rolf Fronczek; Mink Sebastian Schinkelshoek; Frederik Willem Cornelis Roelandse; Jaap Adriaan Bakker; Sebastiaan Overeem; Denise Bijlenga; Gert Jan Lammers Journal: Sleep Date: 2022-03-07 Impact factor: 6.313